• Reference Citation Analysis
  • v
  • v
  • Find an Article
Find an Article PDF (5074679)   Today's Articles (206)
For: Rangone B, Ferrari B, Astesana V, Masiello I, Veneroni P, Zanellato I, Osella D, Bottone MG. A new platinum-based prodrug candidate: Its anticancer effects in B50 neuroblastoma rat cells. Life Sci 2018;210:166-176. [PMID: 30144454 DOI: 10.1016/j.lfs.2018.08.048] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/12/2018] [Revised: 07/27/2018] [Accepted: 08/20/2018] [Indexed: 01/11/2023]
Number Cited by Other Article(s)
1
Gaiaschi L, Casali C, Stabile A, D'Amico S, Ravera M, Gabano E, Galluzzo A, Favaron C, Gola F, De Luca F, Pellegatta S, Bottone MG. DNA Damage Repair in Glioblastoma: A Novel Approach to Combat Drug Resistance. Cell Prolif 2025:e13815. [PMID: 39866010 DOI: 10.1111/cpr.13815] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/05/2024] [Revised: 11/18/2024] [Accepted: 01/15/2025] [Indexed: 01/28/2025]  Open
2
Favaron C, Gaiaschi L, Casali C, De Luca F, Gola F, Cavallo M, Ramundo V, Aldieri E, Milanesi G, Visonà SD, Ravera M, Bottone MG. Unraveling Novel Strategies in Mesothelioma Treatments Using a Newly Synthetized Platinum(IV) Compound. Pharmaceutics 2024;16:1015. [PMID: 39204360 PMCID: PMC11359418 DOI: 10.3390/pharmaceutics16081015] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/14/2024] [Revised: 07/22/2024] [Accepted: 07/22/2024] [Indexed: 09/04/2024]  Open
3
Gaiaschi L, De Luca F, Roda E, Ferrari B, Casali C, Inguscio CR, Gola F, Pelloni E, Savino E, Ravera M, Rossi P, Bottone MG. A Phyto-mycotherapeutic Supplement, Namely Ganostile, as Effective Adjuvant in Brain Cancer Management: An In Vitro Study Using U251 Human Glioblastoma Cell Line. Int J Mol Sci 2024;25:6204. [PMID: 38892392 PMCID: PMC11172483 DOI: 10.3390/ijms25116204] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/16/2024] [Revised: 05/28/2024] [Accepted: 05/31/2024] [Indexed: 06/21/2024]  Open
4
Yu S, Xiao H, Ma L, Zhang J, Zhang J. Reinforcing the immunogenic cell death to enhance cancer immunotherapy efficacy. Biochim Biophys Acta Rev Cancer 2023;1878:188946. [PMID: 37385565 DOI: 10.1016/j.bbcan.2023.188946] [Citation(s) in RCA: 17] [Impact Index Per Article: 8.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/15/2023] [Revised: 06/22/2023] [Accepted: 06/26/2023] [Indexed: 07/01/2023]
5
Gabano E, Gariboldi MB, Marras E, Barbato F, Ravera M. Platinum(IV) combo prodrugs containing cyclohexane-1R,2R-diamine, valproic acid, and perillic acid as a multiaction chemotherapeutic platform for colon cancer. Dalton Trans 2023;52:11349-11360. [PMID: 37530512 DOI: 10.1039/d3dt01876h] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 08/03/2023]
6
Gaiaschi L, Favaron C, Casali C, Gola F, De Luca F, Ravera M, Roda E, Rossi P, Bottone MG. Study on the activation of cell death mechanisms: in search of new therapeutic targets in glioblastoma multiforme. Apoptosis 2023:10.1007/s10495-023-01857-x. [PMID: 37244884 DOI: 10.1007/s10495-023-01857-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 05/20/2023] [Indexed: 05/29/2023]
7
Alajrawy OI, Hadi HA, Awad Al-Luhaibi RS, Sabbar BA. In-vitro cytotoxic activity and theoretical investigations for new mononuclear Pt(IV) and dinuclear Ru(III) with o-phenylenediamine ligand complexes against L20B cell line. RESULTS IN CHEMISTRY 2023. [DOI: 10.1016/j.rechem.2022.100712] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/14/2022]  Open
8
The power of a novel combined anticancer therapy: challenge and opportunity of micotherapy in the treatment of Glioblastoma Multiforme. Biomed Pharmacother 2022;155:113729. [PMID: 36166961 DOI: 10.1016/j.biopha.2022.113729] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/20/2022] [Revised: 09/13/2022] [Accepted: 09/19/2022] [Indexed: 11/21/2022]  Open
9
Gabano E, Gariboldi MB, Caron G, Ermondi G, Marras E, Vallaro M, Ravera M. Application of the anthraquinone drug rhein as an axial ligand in bifunctional Pt(IV) complexes to obtain antiproliferative agents against human glioblastoma cells. Dalton Trans 2022;51:6014-6026. [PMID: 35352739 DOI: 10.1039/d2dt00235c] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
10
Ravera M, Gabano E, McGlinchey MJ, Osella D. Pt(IV) antitumor prodrugs: dogmas, paradigms, and realities. Dalton Trans 2022;51:2121-2134. [PMID: 35015025 DOI: 10.1039/d1dt03886a] [Citation(s) in RCA: 35] [Impact Index Per Article: 11.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/16/2022]
11
Gabano E, Rangone B, Perin E, Caron G, Ermondi G, Vallaro M, Gandin V, Marzano C, Barbanente A, Margiotta N, Ravera M. Pt(iv) complexes based on cyclohexanediamines and the histone deacetylase inhibitor 2-(2-propynyl)octanoic acid: synthesis, characterization, cell penetration properties and antitumor activity. Dalton Trans 2021;50:4663-4672. [PMID: 33725031 DOI: 10.1039/d0dt04135a] [Citation(s) in RCA: 10] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/13/2022]
12
Novel Benzimidazole- Platinum(II) Complexes: Synthesis, Characterization, Antimicrobial and Anticancer Activity. J Mol Struct 2021. [DOI: 10.1016/j.molstruc.2020.129785] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/25/2023]
13
Ferrari B, Roda E, Priori EC, De Luca F, Facoetti A, Ravera M, Brandalise F, Locatelli CA, Rossi P, Bottone MG. A New Platinum-Based Prodrug Candidate for Chemotherapy and Its Synergistic Effect With Hadrontherapy: Novel Strategy to Treat Glioblastoma. Front Neurosci 2021;15:589906. [PMID: 33828444 PMCID: PMC8019820 DOI: 10.3389/fnins.2021.589906] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/31/2020] [Accepted: 02/08/2021] [Indexed: 12/18/2022]  Open
14
Ghavami G, Muhammadnejad S, Amanpour S, Sardari S. Bioactivity Screening of Mulberry Leaf Extracts and two Related Flavonoids in Combination with Cisplatin on Human Gastric Adenocarcinoma Cells. IRANIAN JOURNAL OF PHARMACEUTICAL RESEARCH : IJPR 2020;19:371-382. [PMID: 33224244 PMCID: PMC7667550 DOI: 10.22037/ijpr.2020.1101087] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Key Words] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Indexed: 11/18/2022]
15
Ratto D, Ferrari B, Roda E, Brandalise F, Siciliani S, De Luca F, Priori EC, Di Iorio C, Cobelli F, Veneroni P, Bottone MG, Rossi P. Squaring the Circle: A New Study of Inward and Outward-Rectifying Potassium Currents in U251 GBM Cells. Cell Mol Neurobiol 2020;40:813-828. [PMID: 31845161 PMCID: PMC11448950 DOI: 10.1007/s10571-019-00776-3] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/29/2019] [Accepted: 12/09/2019] [Indexed: 12/18/2022]
16
New Platinum-Based Prodrug Pt(IV)Ac-POA: Antitumour Effects in Rat C6 Glioblastoma Cells. Neurotox Res 2019;37:183-197. [PMID: 31240667 DOI: 10.1007/s12640-019-00076-0] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/30/2019] [Revised: 03/30/2019] [Accepted: 06/13/2019] [Indexed: 02/07/2023]
17
Ravera M, Gabano E, McGlinchey MJ, Osella D. A view on multi-action Pt(IV) antitumor prodrugs. Inorganica Chim Acta 2019. [DOI: 10.1016/j.ica.2019.04.025] [Citation(s) in RCA: 47] [Impact Index Per Article: 7.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/14/2023]
18
Sabbatini M, Zanellato I, Ravera M, Gabano E, Perin E, Rangone B, Osella D. Pt(IV) Bifunctional Prodrug Containing 2-(2-Propynyl)octanoato Axial Ligand: Induction of Immunogenic Cell Death on Colon Cancer. J Med Chem 2019;62:3395-3406. [PMID: 30879295 DOI: 10.1021/acs.jmedchem.8b01860] [Citation(s) in RCA: 52] [Impact Index Per Article: 8.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/06/2023]
PrevPage 1 of 1 1Next
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA